AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 SEP 2 - (NewsRx.com & NewsRx.net) -- INAMED Corporation (IMDC) has filed 7-year deflation rate follow-up data with the U.S. Food and Drug Administration (FDA) for augmentation and reconstruction patients who are participating in the core clinical study of its Biocell Textured and Smooth Saline-Filled Breast Implants.
The 7-year data are an interval update for product labeling that is required by the FDA as part of the Post Approval Survey Study that was a condition of approval for Inamed's saline-filled breast implants in 2000.
The 7-year data build on the existing 5-year data that were previously filed with the FDA.
...